
|Articles|November 1, 2004
Hylaform Plus wins FDA nod for wrinkle correction
National report - The U.S. Food and Drug Administration (FDA) has approved Hylaform Plus (Hylan-B gel), a large-particle-size hyaluronic acid-based dermal filler indicated for the correction of moderate to severe facial wrinkles and folds.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














